Milano Vincent
- SEC CIK
- 0001187159
No open-market purchases or sales filed in the past year.
Current role at each company
- BCRX Biocryst Pharmaceuticals IncDirectoras of Sep 2, 2026
- ACRS Aclaris Therapeutics, Inc.Directoras of Jun 8, 2026
- ACGN Aceragen, Inc.Directoras of Aug 11, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Milano Vincent as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BCRX Biocryst Pharmaceuticals Inc
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 22, 2024 (view filing) | May 20 | 2 days | Milano VincentDirector | PPurchase | +15.0K | $6.25 | +$93.8K | +28.8%67.0K after | |
| Nov 24, 2021 (view filing) | Nov 24 | Same day | Milano VincentDirector | PPurchase | +7.50K | $12.19 | +$91.4K | +75.0%17.5K after |
ACGN Aceragen, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2023 (view filing) | Aug 10 | 1 day | Milano VincentDirector | SSale | −3.28K | $0.53 | −$1.74K | −26.8%8.99K after |